Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cisplatin liposomal

Known as: Cisplatin, Liposomal, Liposomal Cisplatin 
A synthetic formulation in which the antineoplastic agent cisplatin is encapsulated in lipids. Cisplatin liposomal consists of small aggregates of… Expand
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Cisplatin

Narrower (2)

SPI-77, liposomalStealth liposomal cisplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Meta-analysis of clinical trials comparing the efficacy and safety of liposomal cisplatin versus conventional nonliposomal cisplatin in nonsmall cell lung cancer (NSCLC) and squamous cell carcinoma…
Background: While liposomal cisplatin has shown enhanced drug tolerability and higher targeting property as compared with the… Expand
Review
2009
Review
2009
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
  • T. Boulikas
  • Expert opinion on investigational drugs
  • 2009
    • Corpus ID: 27655302
Nanoparticle formulations for packaging existing drugs have been used to treat cancer. Lipoplatin™ is a liposomal cisplatin… Expand
1999
1999
Antitumor activity of Herceptin in combination with STEALTH liposomal cisplatin or nonliposomal cisplatin in a HER2 positive human breast cancer model.
Single agent antitumor activity of Herceptin, a humanized monoclonal antibody directed against HER2, has been demonstrated in… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE